Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism
Update: 2023-10-27
Share
Description
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.
Comments
In Channel



